Both type 1 and type 2 diabetes are associated with increased blood concentrations of several inflammatory biomarkers, including C-reactive protein (CRP), interleukin (IL)-2, IL-6 and tumour necrosis factor-alpha (TNF-α) [2–4]. This evidence concerns the gene CRP and type 2 diabetes mellitus.